comprehensive -WSS

comprehensive

author：comprehensive 2025-10-04 07:15:34 - browse：173

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： HHS suspends federal funding for EcoHealth Alliance

entertainment

WSS

Lilly’s weekly insulin works as well as daily products, new studies show

Boston hospital trains restaurant workers on naloxone for overdoses

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Obesity drug from Roche shows promise in early study

Boston hospital trains restaurant workers on naloxone for overdoses

What a koala virus tells us about the human genome

knowledge

comprehensive

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Tori Bowie and the unacceptable rates of Black maternal death

Oak Street deal isn't the answer to health care's woes

Medicare details structure of new drug price negotiation program

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Hollywood unions extend contract negotiations for actors

Why you get paid to donate plasma but not blood

Moonlake's readout produced a cash windfall. Risks remain

Manchin plays down potential 3rd

Wikipedia

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Lilly’s weekly insulin works as well as daily products, new studies show

ALS treatment from Biogen, Ionis fails in study

ALS treatment from Biogen, Ionis fails in study

WuXi Biologics beefs up its lobbying operation

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

focus

entertainment

entertainment

leisure time